From Diagnosis to Recovery: Charting the Path of Children With Chronic Inflammatory Demyelinating Polyneuropathy in a...

Area of Science:

• Pediatric Neurology
• Clinical Immunology
• Neurophysiology

Background:

• Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder affecting peripheral nerves.
• Pediatric CIDP presents diagnostic and therapeutic challenges, particularly in resource-limited settings.
• Understanding clinical profiles and treatment responses is crucial for optimizing management.

Purpose of the Study:

• To evaluate the clinical characteristics and treatment outcomes of pediatric CIDP patients.
• To assess the efficacy of intravenous pulse methylprednisolone therapy in this population.
• To highlight the role of corticosteroids in managing pediatric CIDP in low-resource environments.

Main Methods:

• Retrospective analysis of 5 pediatric CIDP cases over 3 years at a northern Indian pediatric neurology clinic.
• Clinical data collection including age, subtype (motor-sensory vs. pure motor), and neurological examination findings.
• Assessment of treatment response to intravenous pulse methylprednisolone, with additional therapies (IVIg, rituximab) noted.

Main Results:

• The study included children aged 2.5-13 years, with a 3:2 male-to-female ratio.
• All patients showed positive responses to intravenous pulse methylprednisolone; 60% had good responses, 40% partial.
• 60% achieved disability-free status, and 40% reached stable, nonprogressive conditions post-treatment.

Conclusions:

• Intravenous pulse methylprednisolone is an effective first-line treatment for pediatric CIDP, even in low-resource settings.
• Accurate nerve conduction studies are vital for diagnosis and management.
• Corticosteroids play a critical role in achieving favorable long-term outcomes in pediatric CIDP.